Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Leonardo DRS Exceeds Q3 Expectations Falls Short of FY24 Projections

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Aerospace and Defense Stock Market Today (1)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Leonardo DRS has exceeded expectations by reporting an adjusted diluted EPS of $0.20 for the third quarter of 2023. This surpasses the analyst estimate of $0.16. Looking ahead to fiscal year 2024, the company anticipates an adjusted EPS in the range of $0.74 to $0.82, falling short of the estimated $0.83. Revenue projections for FY24 are expected to be between $2.925 billion and $3.025 billion, slightly lower than the estimated $2.970 billion.

DRS Stock Price Analysis: Potential Buying Opportunity Despite Slight Decrease on February 27, 2024

On February 27, 2024, DRS stock experienced a slight decrease in its price, trading near the top of its 52-week range and above its 200-day simple moving average. The stock opened at $21.50, $0.41 higher than its previous close, but ultimately dropped $0.60, a 2.84% decrease from the previous day’s closing price.

Despite the drop in price on this particular day, DRS has been performing well overall, trading near the top of its 52-week range. This indicates that the stock has been experiencing positive momentum and may have potential for further growth in the future. Additionally, the fact that DRS is trading above its 200-day simple moving average is a positive sign for investors.

While the slight decrease in price on February 27 may be a cause for concern for some investors, it is important to consider the overall performance of DRS in the context of its recent price movements. The stock has shown resilience and strength, and the drop in price may present a buying opportunity for investors looking to capitalize on potential future growth.

DRS Stock Shows Strong Financial Performance with Promising Results in 2024

On February 27, 2024, DRS stock showed promising performances as the company reported strong financial results for the past year and the third quarter. According to data from CNN Money, DRS’s total revenue for the past year was $2.69 billion, representing a 6.46% decrease compared to the previous year. However, the company saw a significant 11.94% increase in total revenue since the last quarter, reaching $703.00 million.

Net income for DRS also saw positive growth, with a net income of $405.00 million for the past year and $47.00 million for the third quarter. This represents a remarkable 162.99% increase in net income since the previous year and a solid 34.29% increase since the last quarter.

Earnings per share (EPS) for DRS stood at $1.88 for the past year and $0.18 for the third quarter. The company experienced a substantial 77.71% increase in EPS since the previous year and a notable 33.79% increase since the last quarter.

Overall, DRS’s stock performances on February 27, 2024, reflect a positive trend in the company’s financial performance. Investors and analysts may view these results as a positive indicator of DRS’s future prospects and may consider the stock as a potential investment opportunity.

Tags: DRS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare-IT-and-tech

ENDRA Life Sciences Inc Partners with Kings College Hospital for Liver Fat Assessment Study

Finances-and-tech

Financial Projections for International Money Express in 2024

Food Producers Trading online

Portillos Projects Significant Growth in Restaurant Units and Revenue

Recommended

Amazon_charge

Positive Outlook for Novo Nordisks Obesity Drug Wegovy and the Future of Obesity Drugs

2 years ago
Food Retailers Stock Market Today

DA Davidson Analyst Reaffirms Buy Rating on Campbell Soup with Lowered Price Target

2 years ago

Everest Re Group Sees Reduction in Stake by Allspring Global Investments Holdings LLC Amidst Strong Financial Performance

2 years ago
Regenxbio Stock

Regenxbio Shares Slide as FDA Pushes Back Key Drug Decision

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Gladstone Capital Executes Strategic Debt Refinancing and Rewards Shareholders

Executive Share Sales and Management Shifts Raise Questions at Repay Holdings

EU Data Act Fuels Momentum for Cybersecurity ETF

Dentsply Sirona’s Rocky Road to Recovery

Trending

BioNTech Stock
Earnings

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

by Andreas Sommer
September 22, 2025
0

The German biotechnology firm BioNTech is navigating a critical strategic transition. Having achieved global recognition through its...

Nestle Stock

Leadership Crisis at Nestlé Sparks Investor Concerns

September 22, 2025
Standex Stock

Standex Shares Plunge Amid Technical Warnings and Insider Selling

September 22, 2025
Synchrony Stock

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

September 22, 2025
Vanguard Information Technology Index Fund ETF Shares Stock

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation
  • Leadership Crisis at Nestlé Sparks Investor Concerns
  • Standex Shares Plunge Amid Technical Warnings and Insider Selling

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com